The aim of this study was to investigate the associations of germ line mutations in selected non‐BRCA1/2 genes with BC risk and BC phenotype in a sample of 5589 BRCA1/2 negative BC index patients who were recruited and counseled at university hospital‐based centers of the GC‐HBOC. The gene discussed is BRCA1; the disease is breast cancer.